Home
Protagonist Therapeutics, Inc.

Protagonist Therapeutics... Market Share Analysis for March 2026

Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs.

Health > Biotechnology and Pharmaceuticals

Domainprotagonist-inc.com

Year Founded2007

Employees51 - 200

Annual Revenue$200M - $500M

Protagonist Therapeutics, Inc.

Protagonist Therapeutics, Inc. (including company regionals)

protagonist-inc.com

See more website traffic and engagement information

Protagonist Therapeutics, Inc. Revenue up to March 2026 is 200M - 500M

revenue generated by Protagonist Therapeutics, Inc. top domains

Protagonist Therapeutics, Inc. top domains revenue over 3 years

Revenue for Protagonist Therapeutics, Inc. top domains

protagonist-inc.com200M - 500M

See more with Sales Intelligence

Total visits to Protagonist Therapeutics, Inc.'s top domains

Understand Protagonist Therapeutics, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

protagonist-inc.com9K

See more with Sales Intelligence

Avg. visit duration in Protagonist Therapeutics, Inc.'s top domains

Analyze Protagonist Therapeutics, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

protagonist-inc.com00:00:15

See more with Sales Intelligence

Avg. pageviews on Protagonist Therapeutics, Inc.'s top domains

See how Protagonist Therapeutics, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

protagonist-inc.com2.36

See more with Sales Intelligence

Protagonist Therapeutics, Inc. top competitors by domain

Top similar sites in March 2026, ranked by their affinity

annexonbio.comCompany NameAnnexon BiosciencesEmployees51 - 200HQUnited States, California, BrisbaneAnnual revenue$15M - $25MTotal visits5.2KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Protagonist Therapeutics, Inc.

These are the website technologies, by industry, used by Protagonist Therapeutics, Inc. top domains

Conversion & Analytics (3)

Google Analytics

Mobile (3)

Meta Viewport

Advertising (2)

Google Adsense

Content Management System (2)

WordPress

More Technologies

8

See all

News & Signals from Protagonist Therapeutics, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAbbVie identified as competitor of Protagonist Therapeutics.AbbVie is ready to face off against the newest kid on the immunology block: Johnson & Johnson and Protagonist Therapeutics' peptide pill Icotyde.

NewsProtagonist Therapeutics attends event 67th Annual American Society of Hematology (ASH) Annual Meeting.NEWARK, Calif. & OSAKA, Japan & CAMBRIDGE, Mass. - Protagonist Therapeutics, Inc. ("Protagonist") ( NASDAQ:PTGX) and Takeda ( TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition.

NewsProtagonist Therapeutics attends event 67th Annual ASH Meeting.Protagonist Therapeutics announces oral and Poster presentations on rusfertide at the 67th Annual ASH Meeting.